The Secondary Prevention Trial for Ischemic Stroke With DengzhanShengmai Capsule "SPIRITDZSM1"

Completed

Phase 4 Results N/A

Summary of Purpose

In order to observe the secondary preventive effect of the Dengzhanshengmai capsule on ischemic stroke, the investigators hold the large randomized control trial (RCT). 3143 subjects are included in 83 clinical research centers all over China. The subjects are randomly grouped into two groups. The basic therapy included antiplatelet aggregation, stroke health education, management of blood pressure, blood lipid...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 5 August 2013.

1 Dec 2007 11 Oct 2007 1 Jan 2011 1 Jan 2011 1 Aug 2013 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Prevention
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts